Notes in Acute lymphoblastic leukaemia (ALL)

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Paeds \| Haem \| ALL \| 1.1 \| Definition
Published	02/18/2024	Paeds \| Haem \| ALL \| 1.2 \| Epidemiology
Published	02/18/2024	Paeds \| Haem \| ALL \| 1.3 \| Aetiology
Published	02/18/2024	Paeds \| Haem \| ALL \| 1.4.1 \| Pathology
Published	02/18/2024	Paeds \| Haem \| ALL \| 1.5 \| Clinical presentation
Published	02/18/2024	Paeds \| Haem \| ALL \| 1.6 \| Biologic behaviour
Published	02/18/2024	Paeds \| Haem \| ALL \| 2.1 \| Workup
Published	02/18/2024	Paeds \| Haem \| ALL \| 2.2 \| Prognostic factors
Published	02/18/2024	Paeds \| Haem \| ALL \| 2.3 \| Risk stratification
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.1 \| Management overvivew
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.2.1 \| Induction chemotherapy
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.2.2 \| CNS prophylaxis
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.2.6 \| Maintenance chemotherapy
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.2.3 \| Consolidation chemotherapy
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.3.1 \| Radiotherapy - summary of indications
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.3.2 \| Cranial RT technique
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.3.3 \| Testicular ALL
Published	02/18/2024	Paeds \| Haem \| ALL \| 4 \| Outcomes
Published	02/18/2024	Paeds \| Haem \| ALL \| 2.4 \| CNS stratification
Published	02/18/2024	Paeds \| Haem \| ALL \| 1.4.2 \| 2016 WHO classification
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.2.4 \| Delayed intensification chemotherapy
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.2.5 \| Allogeneic stem cell transplant
Published	02/18/2024	Paeds \| Haem \| ALL \| 3.4 \| Relapse
Status	Last Update	Fields